XML 57 R47.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information (Details) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Information    
Interest income $ 187,612 $ 44,168
Net loss (5,537,069) (1,066,947)
Single reportable segment    
Segment Information    
Program expenses related to clinical-stage product candidates (4,217,214) (5,912,029)
Program expenses related to preclinical and discovery programs (30,600) (108,338)
Personnel-related expenses (including stock-based compensation) (1,397,874) (1,194,687)
General and administrative professional and consultant fees (444,865) (369,353)
Other segment items (192,128) (225,400)
Interest income 187,612 44,168
Other non-cash income (expense) items 558,000 6,698,692
Net loss $ (5,537,069) $ (1,066,947)